Pfizer Inc 2016 AR2
The report highlights Pfizer's progress in 2016, achieving its second consecutive year of operational revenue growth to reach $52.8 billion. The company advanced its pipeline to 96 assets, secured five product approvals, and expanded access to medicines, including delivering its 250 millionth dose of Prevenar 13 to Gavi. Pfizer also made progress toward its 2020 environmental sustainability goals, reducing greenhouse gas emissions by 20% and waste by 15% compared to a 2012 baseline. Additionally, the company launched its first corporate advertising campaign in a decade and continued to foster its OWNIT! ownership culture among its 96,500 employees.
Company: Pfizer Inc
Sector: Manufacturing
Country: United States
Year: 2016
Type: AR2
Pages: 139
Back to company
Pfizer Inc
Annual Review
The report highlights Pfizer's progress in 2016, achieving its second consecutive year of operational revenue growth to reach $52.8 billion. The company advanced its pipeline to 96 assets, secured five product approvals, and expanded access to medicines, including delivering its 250 millionth dose of Prevenar 13 to Gavi. Pfizer also made progress toward its 2020 environmental sustainability goals, reducing greenhouse gas emissions by 20% and waste by 15% compared to a 2012 baseline. Additionally, the company launched its first corporate advertising campaign in a decade and continued to foster its OWNIT! ownership culture among its 96,500 employees.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Employees